MPX Bioceutical ULC
Summary
MPX Bioceutical ULC is registered in Canada and entered in the “Corporate Registry (Province of British Columbia)” under number BC1196667. Its legal form is Company (includes community contribution company and unlimited liability company) (Ltd.). According to GLEIF, its ultimate parent is iAnthus Capital Holdings Inc. (Canada), which is also its direct parent. That group has 1 subsidiary with LEIs in 1 country, 1 of them in Canada. The LEI was first issued on 30 Oct 2015 and the record was last updated on 8 Aug 2023. It has lapsed: renewal was due by 13 Aug 2020. GLEIF's ISIN mapping lists 6 ISINs for this LEI. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 13 Aug 2020 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2018, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 8 Aug 2023.
Company details
| Legal form | Company (includes community contribution company and unlimited liability company) (Ltd.) |
|---|---|
| Register | Corporate Registry (Province of British Columbia) · Register website |
| Registration number | BC1196667 |
| Registration authority | BC Registry Services |
| Jurisdiction | Canada (CA-BC) |
| Registered address | 1055 West Georgia Street, 1500 Royal Centre, P.O. Box 11117, V6E 4N7 Vancouver, Canada |
| Headquarters address | 22 Adelaide Street West, Suite 2740, M5H 4E3 Toronto, Canada |
| Category | company or other legal entity |
| Status | active |
| LEI | 5493007OH91L5O0U6793 |
| LEI status | lapsed |
| LEI first issued | 30 Oct 2015 |
| LEI record last updated | 8 Aug 2023 |
| Next LEI renewal | 13 Aug 2020 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | iAnthus Capital Holdings Inc. | iAnthus Capital Holdings Inc. |
| Accounting period | 1 Jan 2018 to 31 Dec 2018 | 1 Jan 2018 to 31 Dec 2018 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Accounting standard | IFRS | IFRS |
| Relationship start | 13 Aug 2019 | 13 Aug 2019 |
| Recorded at GLEIF since | 8 Aug 2023 | 8 Aug 2023 |
| Last updated | 8 Aug 2023 | 8 Aug 2023 |
| Record status | not renewed | not renewed |
ISINs mapped to this LEI (6)
US5534431284 · US5534431441 · US5534431516 · US5534433009 · US5534435087 · US5534437067
6 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.
Other names
- The Canadian Bioceutical Corporation · previous name
- MPX Bioceutical Corporation · previous name